Esophageal Squamous Cell Carcinoma Escc clinical trials

Explore recruiting esophageal squamous cell carcinoma escc clinical trials.

Recruiting esophageal squamous cell carcinoma escc studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Esophageal Squamous Cell Carcinoma Escc trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

SAFE-ESO_Phase II study evaluating safety and efficacy of Tislelizumab for elderly patients unfit for chemotherapy, with advanced esophageal squamous-cell carcinoma

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3, Multicenter, Randomized, Open-label Study of Ifinatamab Deruxtecan (I-DXd) in Subjects with Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)

Norway, Poland, Denmark, Italy, Romania, France +5 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Esophageal Squamous Cell Carcinoma Escc trials by city

Esophageal Squamous Cell Carcinoma Escc clinical trials

Recruiting esophageal squamous cell carcinoma escc studies right now

Adebrelimab ±Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Unresectable Locally Advanced ESCC

Adebrelimab Neoadjuvant Treatment for Resectable ESCC: 2 vs 4 Cycles Study

Hypofractionated vs. Conventional Chemoradiotherapy After Induction Chemo-immunotherapy for Unresectable Esophageal Squamous Cell Carcinoma

AK112 Combined With Chemotherapy as the First-line Treatment in Advanced Esophageal Squamous Cell Carcinoma Patients

CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC

A Study of IO Plus Radiotherapy in Patients With Advanced ESCC.

Time-of-Day of Immunotherapy Infusion in Neoadjuvant Immunochemotherapy for Thoracic ESCC

A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)

Low-Dose Involved-Field Radiotherapy Plus Immunochemotherapy for ESCC

Combination Immunotherapy of Adebrelimab With Apatinib and Tegafur, Gimeracil and Oteracil Potassium Capsules for Immune Rechallenge Therapy in Esophageal Squamous Cell Carcinoma

A Study of Perioperative Camrelizumab Combined With Chemotherapy in Patients With Resectable ESCC

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

Also recruiting in Europe

SAFE-ESO_Phase II study evaluating safety and efficacy of Tislelizumab for elderly patients unfit for chemotherapy, with advanced esophageal squamous-cell carcinoma

A Phase 3, Multicenter, Randomized, Open-label Study of Ifinatamab Deruxtecan (I-DXd) in Subjects with Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)

Esophageal Squamous Cell Carcinoma Escc trials by city

Other conditions